Engineered exosome-mediated delivery of functionally active miR-26a and its enhanced suppression effect in HepG2 cells [Erratum]

This article refers to:

Engineered exosome-mediated delivery of functionally active miR-26a and its enhanced suppression effect in HepG2 cells

Liang G, Kan S, Zhu Y, et al. Int J Nanomedicine. 2018;13:585–599.

On page 586, the 1st heading, right hand column should read “Materials and methods” instead of “Patients and methods”.